Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2720 results

Clinical Trials / Jun 05, 2025

Secukinumab Open Label Roll-over Extension Protocol
Clinical Trials / Jun 26, 2025

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
Clinical Trials / Dec 27, 2024

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Clinical Trials / Jun 29, 2025

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
Clinical Trials / Jun 29, 2025

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Press release / Jul 03, 2025

Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1Safety in GCA patients was consistent with known safety profile…
Featured News / Jan 13, 2020

Novartis at J.P Morgan 2020

From January 13-16 2020, Novartis attended the J.P Morgan Healthcare Conference in San Francisco.
Third-party suppliers
External Partner Risk Management (EPRM)
Sourcing and Procurement

‹ Previous page
1
…
17
18
19
20
21
22
23
…
272
› Next page